NEPHROPLUSNSENephrocare Health Services LimitedMediumPositive
Announced Tue, 26 May · 22:19 IST

Nephrocare Health Services Limited has informed that Nephrocare Health Services International Pte. Ltd, overseas wholly owned subsidiary of the Company has incorporated a new overseas wholly owned subsidiary as per the disclosure enclosed herewith

Strategic Transactions View source PDF

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹607.00
prior close
₹607.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+0.2+0.0+0.6-1.6+5.2+9.2+8.7+8.7+11.2+19.4+8.4+12.5
Up moveDown movePending
AI summary

Nephrocare Health Services International Pte. Ltd., the overseas wholly-owned subsidiary of Nephrocare Health Services Limited, has incorporated a new step-down subsidiary named NEPHROPLUS HEALTH SERVICES KAZAKHSTAN LLP in Kazakhstan on May 26, 2026. The new entity has a charter capital of KZT 5,000,000 (approximately USD 10,500) contributed in cash. The company effectively controls 100% of the step-down subsidiary through its Singapore subsidiary (99%) and a nominee (1% held by Mr. Nishant Saxena). The LLP has been established to expand the company's kidney care and dialysis services network in Kazakhstan, including operating dialysis centres and providing related healthcare services.

Likely market impact

This is a routine disclosure about geographic expansion into a new market. The investment amount is modest (~$10,500) and unlikely to have any immediate material impact on the company's financials or stock price. It signals the company's intent to grow its dialysis services internationally.